rediff.com
e.g. Tata motors, Reliance MF, 500570
Aurobindo Pharma Ltd. - Research Center
524804 AUROPHARMA Group (A) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Cash flow
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Profit before tax 2,402.92 1,614.35 1,637.48 4,193.01 2,377.70
Net cashflow-operating activity 1,714.80 1,821.16 3,726.71 2,994.41 2,161.73
Net cash used in investing activity -159.96 -3,459.68 -1,613.51 -2,648.73 -921.57
Netcash used in fin. activity -1,837.03 1,719.48 -2,447.54 -27.94 -1,252.39
Net inc/dec in cash and equivlnt -273.81 81.44 -335.37 316.23 -9.26
Cash and equivalnt begin of year 357.13 48.21 383.58 67.35 68.70
Cash and equivalnt end of year 83.32 129.65 48.21 383.58 59.44
Close
Add Aurobindo Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Aurobindo Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close